1. Home
  2. GHLD vs MNKD Comparison

GHLD vs MNKD Comparison

Compare GHLD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • MNKD
  • Stock Information
  • Founded
  • GHLD 1960
  • MNKD 1991
  • Country
  • GHLD United States
  • MNKD United States
  • Employees
  • GHLD N/A
  • MNKD N/A
  • Industry
  • GHLD Finance: Consumer Services
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • MNKD Health Care
  • Exchange
  • GHLD Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • GHLD 1.2B
  • MNKD 1.2B
  • IPO Year
  • GHLD 2020
  • MNKD 2004
  • Fundamental
  • Price
  • GHLD $19.97
  • MNKD $5.39
  • Analyst Decision
  • GHLD Hold
  • MNKD Strong Buy
  • Analyst Count
  • GHLD 6
  • MNKD 5
  • Target Price
  • GHLD $18.10
  • MNKD $10.80
  • AVG Volume (30 Days)
  • GHLD 39.5K
  • MNKD 5.8M
  • Earning Date
  • GHLD 11-05-2025
  • MNKD 11-06-2025
  • Dividend Yield
  • GHLD 3.75%
  • MNKD N/A
  • EPS Growth
  • GHLD N/A
  • MNKD 149.32
  • EPS
  • GHLD 0.42
  • MNKD 0.11
  • Revenue
  • GHLD $1,125,872,000.00
  • MNKD $301,736,000.00
  • Revenue This Year
  • GHLD $1.68
  • MNKD $16.36
  • Revenue Next Year
  • GHLD $21.80
  • MNKD $20.34
  • P/E Ratio
  • GHLD $47.86
  • MNKD $50.42
  • Revenue Growth
  • GHLD 23.19
  • MNKD 21.48
  • 52 Week Low
  • GHLD $11.21
  • MNKD $3.38
  • 52 Week High
  • GHLD $23.57
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 59.27
  • MNKD 63.64
  • Support Level
  • GHLD $19.82
  • MNKD $5.25
  • Resistance Level
  • GHLD $20.25
  • MNKD $5.77
  • Average True Range (ATR)
  • GHLD 0.13
  • MNKD 0.29
  • MACD
  • GHLD -0.01
  • MNKD -0.01
  • Stochastic Oscillator
  • GHLD 38.73
  • MNKD 54.75

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: